<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392063</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU MD 202/2016</org_study_id>
    <nct_id>NCT04392063</nct_id>
  </id_info>
  <brief_title>Melatonin for Cerebral Palsy Children's Sleep and Health</brief_title>
  <official_title>Effect of Melatonin Supplementation on Sleep and Health of Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study was prospective uncontrolled, single-armed and un-blinded study. Held in
      the Pediatric neurology clinic, Children's hospital l, Faculty of Medicine, Ain Shams
      University from June 2016 to June 2018 of 24 months timeframe. All cerebral palsy (CP)
      patients following up in Pediatric neurology clinic aged between 2 and 12 years. Melatonin
      given for 3 months. Anthropmetric measures, gastroeintestinal symptoms, Children's sleep
      habits questionnaire (CSHQ) Arabic version, polysomnography, Chalfont epilepsy severity
      score, and EEG were done at enrollment and after the 3-months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, cohort study conducted in Pediatric Neurology Clinic, Children's Hospital,
      Faculty of Medicine, Ain Shams University. Forty children with sCP with sleep and seizure
      problems, aged 2-12 years were enrolled. The children received crushed Melatonin 3-mg tablets
      daily, 30-minutes before bedtime for 3-months. Children's sleep habits questionnaire (CSHQ)
      Arabic version, polysomnography, Chalfont epilepsy severity score, and EEG were done at
      enrollment and after the 3-months. The ethical approval number is (FMASU MD 202/2016).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">September 2018</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A prospective, cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in total Children's sleep habits questionnaire score</measure>
    <time_frame>after 3-months</time_frame>
    <description>response to melatonin as decrease in total sleep score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in growth</measure>
    <time_frame>3-months</time_frame>
    <description>response to melatonin in improvement of growth</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cerebral Palsy</condition>
  <condition>Melatonin</condition>
  <condition>Growth</condition>
  <condition>Children, Only</condition>
  <arm_group>
    <arm_group_label>Cerebral palsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Not included</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin 3 mg</intervention_name>
    <description>The children received crushed Melatonin 3-mg tablets daily, 30-minutes before bedtime for 3-months.</description>
    <arm_group_label>Cerebral palsy</arm_group_label>
    <other_name>Melatonin CP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All cerebral palsy children with sleep problem and seizure disorder,

          -  aged 2 - 12 years

        Exclusion Criteria:

          -  any auditory and peripheral visual impairments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital, Faculty of Medicine, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11381</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>https://platform.almanhal.com/Reader/Article/130441</url>
    <description>Published part of the work &quot;Effect of Melatonin Supplementation on Gastrointestinal Problems and Growth of Children with Cerebral Palsy&quot;</description>
  </link>
  <results_reference>
    <citation>Elkhayat HA, Hassanein SM, Tomoum HY, Abd-Elhamid IA, Asaad T, Elwakkad AS. Melatonin and sleep-related problems in children with intractable epilepsy. Pediatr Neurol. 2010 Apr;42(4):249-54. doi: 10.1016/j.pediatrneurol.2009.11.002.</citation>
    <PMID>20304327</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 10, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Sahar M.A. Hassanein, MD</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Children's sleep habits questionnaire (CSHQ) Arabic version</keyword>
  <keyword>Anthropometry</keyword>
  <keyword>GERD</keyword>
  <keyword>Constipation</keyword>
  <keyword>Polysomnography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

